Somatic cells can be reprogrammed to a pluripotent state by over-expression of defined factors, and pluripotency has been confirmed by the tetraploid complementation assay. However, especially in human cells, estimating the quality of Induced Pluripotent Stem Cell(iPSC) is still difficult. Here, we present a novel supervised method for the assessment of the quality of iPSCs by estimating the gene expression profile using a 2-D “Differentiation-index coordinate”, which consists of two “developing lines” that reflects the directions of ES cell differentiation and the changes of cell states during differentiation. By applying a novel liner model to describe the differentiation trajectory, we transformed the ES cell differentiation time-course expression profiles to linear “developing lines”; and use these lines to construct the 2-D “Differentiation-index coordinate” of mouse and human. We compared the published gene expression profiles of iPSCs, ESCs and fibroblasts in mouse and human “Differentiation-index coordinate”. Moreover, we defined the Distance index to indicate the qualities of iPS cells, which based on the projection distance of iPSCs-ESCs and iPSCs-fibroblasts. The results indicated that the “Differentiation-index coordinate” can distinguish differentiation states of the different cells types. Furthermore, by applying this method to the analysis of expression profiles in the tetraploid complementation assay, we showed that the Distance index which reflected spatial distributions correlated the pluripotency of iPSCs. We also analyzed the significantly changed gene sets of “developing lines”. The results suggest that the method presented here is not only suitable for the estimation of the quality of iPS cells based on expression profiles, but also is a new approach to analyze time-resolved experimental data.
Citation: Zhang B, Chen B, Wu T, Tan Y, Qiu S, Xuan Z, et al. (2011) Estimating the Quality of Reprogrammed Cells Using ES Cell Differentiation Expression Patterns. PLoS ONE 6(1): e15336. https://doi.org/10.1371/journal.pone.0015336
Editor: Costanza Emanueli, University of Bristol, United Kingdom
Received: September 19, 2010; Accepted: November 7, 2010; Published: January 11, 2011
Copyright: © 2011 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by the National Program on Key Basic Research Project (973 Program Grant 2009CB825401), the National Natural Science Foundation of China (60933009), and the Innovation Projects (KSCX2-YW-R-124) from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
As a promising technology, induced pluripotent stem cells (iPSCs) are playing important roles in many fields, including personal therapy and scientific research. Both human and mouse fibroblast cells have been reprogrammed to a pluripotent cell state by the over-expression of several transcription factors (TF) that appear in embryonic stem cells –. In addition, many kinds of somatic cells, including adipose cell, neurons and so on, have also been reprogrammed to a pluripotent cell state by rapidly developing iPS technologies , , , , , .
Similar to ES cells, the pluripotency of iPS cells evoke expectation and enthusiasm. Different experimental and theoretical approaches have been applied to estimate the similarity between iPSCs and ESCs. Among these approaches, microarray technology and clustering analysis are widely used to detect expression patterns during the reprogramming process. Mark  compared the expression profiles of iPSCs and ESCs by clustering analysis and concluded that iPSCs could be considered as a subtype of pluripotent cells. By comparing the percentage of differentially expressed genes between iPSCs and ESCs, Zhumur  estimated several iPS cell lines originated from different cell types. However, it is still difficult to accurately measure the quality of iPSCs based on molecular characteristics and to estimate the pluripotency of ES cells and iPSCs.
Here, we introduce a new supervised method to estimate the quality of iPSCs based on gene expression profiles from the perspective of ES cell differentiation ability. Inspired by the description of differentiation trajectories in a high-dimensional state space, time-resolved expression profiles of ESC differentiation processes were transformed into linear scales, which were named “developing lines” and represent differentiation directions and the changes in gene expression over time. Here, these developing lines were used to measure the transcription profiles of iPSCs and undifferentiated ESCs. If the iPSCs are similar to ESCs, they should have the similar projection positions on these “developing lines”. Moreover, we defined the concept of the Distance index, which reflects a spatial distance, to measure the similarity of each sample to ESCs. This method not only provided an estimation of the quality of iPSCs based on similarities between iPSCs-ESCs and iPSCs-fibroblasts at the transcriptional level but was also a novel approach for the analysis of time-resolved experimental data.
Distinct descriptions of similarities among cell types in mouse and human “Differentiation-index Coordinates”
To construct the mouse “Differentiation-index Coordinate”, dataset GSE10970, which contains a series of time-resolved differentiation gene expression profiles for ESC-derived cardiac precursor cells (CPCs), and dataset GSE3653, which contains a series of time-resolved differentiation gene expression profiles for ESC-derived pancreatic islets (PIs), were transformed to a CPC developing line and PI developing line as described in the Methods. All collected mouse expression profiles of iPSCs, ESCs, partly reprogrammed cells, neuronal progenitor cells and fibroblast cells were estimated by this two-dimensional surface coordinate (Figure 1).
The X-axis is the cardiac precursor cell developing line; the Y-axis is the pancreatic islets developing line. CL11, IP14D-101, IP14D-1 and IP20D-3 are contained in Dataset GSE15925. The red arrows indicate the movement of cell state changes. Ellipses were generated by the mean values and standard variances.
The mouse Differentiation-index coordinate accurately distinguished between the distributions of different cell types and clearly showed the cell state changes during the reprogramming process. The mouse embryonic fibroblast cells were located the largest distance from the ESCs. The partially reprogrammed cells were located in the middle between the ESC region and fibroblast region. iPSCs were located close to the ESC region and partly overlapped with it. Meanwhile, neuronal progenitor cells were located more closely to the ESC region than the fibroblast cells, which indicated a greater similarity between neuronal progenitor cells and ESCs. Recent studies have indicated that compared with the four factors (Oct3/4, Sox2, c-Myc, and Klf4) required to induce fibroblast cells, neuronal progenitor cells could be induced into a pluripotent state by only Oct4 (Pou5f1) expression, . These results suggested that the distance between ESCs and other cell types in the Differentiation-index coordinate not only reflected their cell state and similarities but also partly indicated the difficulty of inducing them to a pluripotent state.
We also included dataset GSE16925, which was generated with the tetraploid complementation assay  and showed whether the mouse iPSCs have the ability to develop into an embryo and mature mice. Based on the large number of ESC expression profiles, it was obvious that IP14 (including three replicates of IP14D-1 and IP14D-101) was very close to the ESC region, while the location of IP20 (including three replicates of IP20D-3) was far away from the ESC region. In their study, by using blastocyst injection, 624 IP14D-1 reprogrammed cells generated 22 live pups (3.5%), 181 IP14D-101 reprogrammed cells generated 4 live pups (2.2%), and 204 IP20D-3 reprogrammed cells did not generate any live pups. The “Differentiation index coordinate” clearly described the relationships among all cell types from this study: IP14D-101 was more similar to CL11 ESCs than to IP14D-1 (a shorter distance between IP14D-101 and CL11), which was confirmed by the hierarchical clustering analysis . Moreover, due to the deviation of the CL11 ESCs, hierarchical clustering analysis may not reflect the qualities of iPSCs in this case.
Then, we selected the GSE9940 dataset of human ES cell-derived neural rosette differentiation expression profiles to generate a human neuronal developing line. The GSE8884 dataset of human ES cell-derived blast cell differentiation expression profiles was used to generate the second axis, a blast cell developing line (blast cells generate both hematopoietic and endothelial progenies upon transfer to the appropriate conditions). Thus, the two-dimensional human “Differentiation-index coordinate” was obtained.
All collected expression profiles of human iPSCs, ESCs and fibroblast cells were estimated using the human Differentiation-index coordinate (Figure 2). The result showed that only part of the iPSCs overlapped with the ESCs, and many iPSCs were still located far away from the ESCs. In addition, we found that the blast cell developing line was more effective and had more resolving power to distinguish iPSCs than the neuronal developing line. For estimating the resolution power of the neuronal developing line for different cell states, we used dataset GSE9921, which contained gene expression profiles of human ESCs and neural rosettes (Figure S1), as a test. The result showed that the neuronal developing line distinguished between the neurons and ESCs. These results indicated that the developing line has the best resolution for distinguishing between corresponding cell types.
The X-axis is the blast cell developing line; the Y-axis is the neuronal developing line. Ellipses were generated by the mean values and standard variances.
The “Differentiation-index coordinate” could be used to generate a clear and intuitive estimation of pluripotency for different kinds of cells, especially iPSCs. In the Differentiation-index coordinate, the distinct projection positions of iPSCs directly demonstrate their similarities to ESCs in different development directions at the transcriptional level. For estimating the similarities of iPSCs accurately, we defined the Distance index (Di), which reflected the distance ratio of iPS cells to ES cells and fibroblast cells. A smaller Distance index () demonstrates a higher similarity of the iPSCs to the center of the ES cells and dissimilarity to the fibroblast cells.
We calculated the Distance indices (Di) for all collected ESCs (Tables S1, S2) and iPSCs (Tables S3, S4) for human and mouse. Based on the Di of human and mouse ESCs, we set the mean value of all ESC Distance indices as the threshold, which was 0.09384 in human and 0.11024 in mouse. This threshold reflects the dispersion of the ESC transcriptome. Eighty percent of human ESCs (24 of 30) and 60% (12 of 20) of mouse ESCs were under the threshold.
We compared the three strains of iPSCs used in the tetraploid complementation assay . Interestingly, the Distance indices of iPSCs reflected their distinct abilities to generate live pups (Table 1). All three repeats of the IP20D-3 strain iPS cells had larger Distance indices than the threshold value (0.11024). However, the three replicates of IP14D-101 had larger variances than the other two cell lines.
Analysis of significant changed genes
The methods presented here are not limited to the estimation of the similarities between different cell types; they could also be applied to the analysis of time-resolved experimental data. When calculating the developing lines, we also defined a weight for each gene to represent the expression change, and then calculated P and FDR values based on distribution of weights. With a P-value cut-off of <0.01 and an FDR of <0.1, we selected the most significantly changed genes in four different ESC differentiation processes. For assessing the functions of these significantly changed genes, we performed GO analysis using the DAVID bioinformatics resource . The results (GO annotation: Tables S5, S6, S7, S8, S9, S10, S11, S12; genes list: Tables S13, S14, S15, S16, S17, S18, S19, S20) indicated that all clustered genes were involved in many morphogenetic processes of different tissues, including stem cell maintenance, prostate gland morphogenesis, neuron projection morphogenesis, gland development and so on. Moreover, some significantly regulated genes were also involved in developmental pathways, such as the retinoic acid and platelet-derived growth factor receptor signaling pathways.
Furthermore, we compared the significantly changed genes between the two experiments and generated a list of “common genes” in both human and mouse (Tables S21, S22, S23, S24). These lists contained the “common” up-regulated and down-regulated genes in the two differentiation processes with different directions and may provide some information about ESC differentiation. After comparing the lists, we found that only two genes appeared in the common lists of both human and mouse genes. POU5F1 (OCT4), which acts as an important factor in the induced pluripotency process, was the only significantly down-regulated gene in the four ESC differentiation processes. However, the NANOG gene was only in the common list for humans, and SOX2 did not appear in the common list. Correspondingly, TTR, a protein transports vitamin A (retinol) and a hormone called thyroxine throughout the body, was the only significantly up-regulated gene in the four experiments. Another important gene in the common list was GUCY1A3, which is a GTP cyclase that generates the second messenger cGMP. These significantly up-regulated common genes suggest that the initiation of cell-cell communication is crucial during ESC differentiation.
To better understand the relationship and function of these genes, we searched for their protein binding partners using protein-protein interaction data (BioGrid, Version 3.0.66). Interestingly, we found a new model that consisted of three components: down-regulated genes, up-regulated genes, and insignificantly changed genes and named it the “Seesaw module” (Figure 3A). The expression of the genes that appeared in the “Seesaw module” directly described the dynamic changes (Figure 4). The genes that appeared in the seesaw modules have been reported to be involved in developmental processes; for example, in the ZBTB16-CD81-IFITM1 module of membrane proteins, CD81 may play an important role in the regulation of lymphoma cell growth  and acts as the receptor for some viruses , and IFITM1 has been implicated in the control of cell growth . Some proteinases and their inhibitors were also found in the Seesaw modules, such as SERPINA1, VTN, KNG1, and KLKB1. These genes may be involved in apoptosis or some tissue morphogenetic processes.
Red: significantly up-regulated genes; Yellow: insignificantly changed genes; Green: significantly down-regulated genes. Red ellipse: the epigenetic regulation seesaw module.
The induced pluripotent stem (iPS) cell technology is an enormously promising approach for personal therapy and scientific research. However, how the cell state alteration process happens from terminal differentiation to pluripotency is unclear. The similarities and differences in the transcriptomes of iPSCs and ES cells have been estimated , , while other properties of iPSCs are also different compared with ESCs, such as the genome methylation state , , microRNA profiling, histone modification, proteomic profiles , and so on. It is still a challenge to find an accurate and easy method to estimate the pluripotency of iPSC candidates based on these cellular properties.
The value of iPSCs is their pluripotency. From this perspective, pluripotency should be a gold standard for estimating the quality of iPSCs . The tetraploid complementation assay, with is the most strict standard, has been successfully performed on mouse cells , . Our results suggested that genome-wide expression patterns could partly reflect the pluripotency of mouse cells. The Distance index of dataset GSE16925 indicated that low quality iPS cells (IP20D-3) distinctly have bigger Di then the high quality iPS cells (IP14D-1), and this disparity is also clearly reflected by the success of live pups. We believe that the Distance index, as a more accurate and reasonable measurement, have the potential to become an easy standard to estimate the quality of iPSCs at molecular level.
The similarity defined by hierarchical clustering method severely depends on the mathematical characteristics of expression profiles. The system error of ES cells expression profiles would affect the clustering results. In our model, the “developing lines” generated by time-ordered linear model have distinct biological meaning: such lines are projection of ES cells differentiation trajectories. Meanwhile, the calculation of Distance index by this supervised method is based on a large number of expression profiles from different laboratories, and these existing datasets give our method greater robustness and accuracy. Such characteristics enable us to compare expression profiles of different sources more easily. Moreover, this method gives a simple and direct description of different cell state distributions. The dynamic changes in cell states induced by reprogramming were also clearly indicated by the “Differentiation-index coordinate”. These dynamic changes of cell states would help us to understand more about the movement trajectories of the ES cells differentiation and the reprogramming process of somatic cells.
As shown, the time-order linear model was also a novel method to analyze time-resolved experimental data. This method generated lists of the significantly up/down regulated genes during the time-resolved experiment. Based on the Protein-protein interaction network and significantly changed genes during human ES cell differentiation, we identified some interesting “seesaw” modules. One of these modules directly regulates the epigenetic changes that occur during the ESC differentiation process: ZBTB16-(HADC1, SIN3A, SUMO1)-DNMT3B. DNMT3B encodes a DNA methyltransferase that is thought to function in genome DNA de novo methylation. HADC1 encodes a histone deacetylase that is responsible for the deacetylation of lysine residues on the N-terminal tails of the core histones (H2A, H2B, H3, and H4). By SUMO1 modification, DNMT3B modulates its interaction with HDAC1 to repress the transcription of target genes . ZBTB16 associates with SIN3A and HDAC1 in vitro and in vivo, and this co-repressor complex down-regulates the expression levels of target genes . Down-regulation of DNMT3B in this epigenetic “seesaw module” indicates that genome methylation is lost during ESC differentiation. Recently, the human genome DNA methylation map was published at single base resolution. Compared with the undifferentiated H1 human embryonic stem cell line, the methylation level of the genome of the fetal lung fibroblast cell line IMR-90 was less than 25%, which is about 1.7*10e7 sites . In particular, most of the mCHG and mCHH modifications were absent from IMR-90 cells; considering the significant down-regulation of the DNMT3B gene, this evidence suggests that DNMT3B may play an important role in the reduction in methylation during development. Moreover, the stable expression of “linker genes” indicates that DNA methylation could provide location information for gene regulation, and histone acetylation and deacetylation might directly control the transcription of target genes.
In this work, we constructed developing lines of some differentiation fates determinations in mouse and human. Theoretically, the developing line had the best resolving power for estimating the cell state of the corresponding cells, i.e, using fibroblast developing line to estimate iPSCs originated from fibroblasts, using the neuronal developing line to estimate iPSCs originated from neurons. However, for the limited number of successful ESC differentiation events in vitro, it is still difficult for us to construct developing lines that represent all directions of every ESC differentiation process. Here, we used two developing lines to estimate the pluripotency of iPSCs and other cells, and the promising results encouraged us to improve this method. Although the resolution powers of the different developing lines still need to assess, we expect that these “Differentiation-index coordinates” could reflect all of cell fates, fit all expression data, or even distinguish all cell types accurately in the future.
The approach presented here could also contribute to the construction of a “Cell type coordinate”, which would reflect the relationship between different cell types and describe the cell type-specific differences at different levels (including RNA expression, protein expression, epigenetic modification, etc.). Recently, the fibroblast cell have been directly reprogrammed to functional neurons and Cardiomyocytes , . Such evidence lights a new approach to reprogramming cell fates. We hope to construct a “Cell type coordinate” in the future, which could show the difference among functional cells at the transcriptional level, how TFs contribute the differentiation in developmental processes, and which TF could be used to induce the transformation different functional cells. Furthermore, investigation of differentiation and improvements in reprogramming technology will help us improve the methods for qualified iPSCs selection for scientific research and clinical applications.
Materials and Methods
Preparation of gene expression profiles
The gene expression data were obtained from the largest expression database, Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/). To construct linear scales that represent the changes in gene expression over differentiation time, we analyzed two datasets that contained the expression profiles of human ESCs differentiating into neural rosettes and blast cells (Table 2).
To estimate iPS cell pluripotency on a large scale, we collected the expression profiles of iPS cells and ESCs based on the Affymetrix Human Genome U133 Plus 2.0 chip (GEO platform: GPL570) if possible (before Oct. 2009). All of the expression profile datasets of human iPSCs and ESCs are listed in Table 3.
We also constructed mouse ES cell differentiation developing lines to estimate the relationship between mouse iPSCs and mouse ESCs. All of the expression profiles were based on the Affymetrix Mouse Genome 430 2.0 chip (GEO platform: GPL1226). Two datasets containing the expression profiles of mouse ES cells differentiating to cardiac precursor cells and pancreatic islets were used to generate two differentiation developing lines (Table 4).
As described above, we collected the expression profiles of mouse iPS cells and mouse ESCs where possible (before Oct. 2009) and analyzed these expression profiles as described in the method (Table 5).
Probe signal estimates were derived from the SOFT files. Each probe was treated as an independent transcript. The log-transformed values of the expression data were then median-normalized independently for each dataset.
Construction of Developing-lines and Differentiation-index coordinate
To construct developing lines that represent ESC differentiation processes, we used a time-ordered linear model algorithm to transform time-resolved ESC's differentiation expression profiles into the Octave environment.
Inspiriting from Clustering ,  and PCA method, this linear model is based on the description of the developmental trajectory as a line with a distinct direction, which represents the gene expression change over developmental time. In order to achieve such aim, tow points must be required:
- the line could preserve the time order of the projected points
- the line could preserve the distance ratio of joint sample points in the microarray space
In high-dimensional space(in this paper, the dimensions are determined by genes number N), a series of unlooped, head-to-tail joint vectors (here which represent sample change at t time points, and N>t) have one co-bisector. Because the angles between each vector and co-bisector are the same, after each vector is projected onto the co-bisector, the strict order and length ratio of every vector is preserved perfectly. Naturally, the co-bisector of a series of vectors has the longest length among all bisectors (Figure S2), and it can represent the moving trend of sample. The co-bisector suited our two requirements for a linear model that represents the processes of tissue development and cell differentiation.
First, we built a microarray space, in which the dimensions were determined by probes that represented transcripts on the microarray chip. Based on the same microarray platform, each expression profile had a unique position in this high-dimensional space.
X is a matrix, which represents the expression data for n genes measured at t time points. Xi represents the expression profile at time point i, for all . The expression score of gene at time point is .(1)
For the purpose of preserving the strict order of the projected points of on the projected line, we first generated (t-1) vectors , forall , and the vectors are given by: (2)
Then, we defined the co-bisector as . The inner product of vector and the co-bisector is , and it should satisfy the equation below: (3)
Naturally, after the points of were projected onto the co-bisector of , the projected points retained their order. Among all co-bisectors that could preserve the distance ratio of these sample points by projection, the co-bisector in the linear subspace determined by , forall , has the longest length. Thus, the optimized could be represented as the linear combination of , forall :(4)
To simplify our calculations, we set to 1:(5)
With equations (2), (3), (4), and (5), the parameters and and vector were determined.
Thus was obtained, and this vector represented the change in the expression level during differentiation from the ESC state to a terminally differentiated state. We named this vector the “developing line”.
When the expression profiles of other samples are projected onto the vector (), the projection position Pi of each sample is calculated by: (6)
This projection position represents the relative similarity at the transcriptional level. To account for similar gene expression states, the same kinds of cells were grouped together, even though the expression data came from different laboratories.
We generated two human ESC differentiation developing lines and two mouse ESC differentiation developing lines that corresponded to four time-resolved ESC differentiation expression profiles. Then all of the collected expression data for ESCs, fibroblast cells and iPSCs were individually projected onto the developing lines. The coordinates of all projection positions were analyzed and visualized with the R software. The projection regions of ESCs, fibroblast cells and iPSCs were determined by the mean values and standard deviations of each cell type.
The microarray approach usually contains the noise which generated from experiment stage. In order to see the robustness of our time-ordered linear model, we selected mice fetal liver development time-course expression profiles to make tests. We randomly replaced the genes expression values of samples in GSE13149, and the genes number of randomly replaced was continuously increased from 1% to 20% of all genes. Then, the modified datasets were calculated to generate modified “developing lines”. Another dataset GSE6998 was projected on these modified “developing lines”. The variance of projection locations indicated the robustness of time-linear model. This model can endure 17% random replacement of total genes (Figure S3, Table S25). Such result showed this linear model has a strong robustness to noise.
Distance index calculation
We defined the concept of a Distance index, which represents the similarity of each sample to ESCs. The centers of the ES cell projection region and the fibroblast cell projection region were set as two anchor points. The Distance index () of sample A was defined as:(7)
In equation (7), and are the projection coordinates values of sample A in the “Differentiation-index coordinate”. A smaller Distance index () indicates that the projection of the sample is closer to the center of the ES cell projection region. The Distance index () was used to generate an estimation for each iPSC. Furthermore, the distribution of the Distance index () of all ESCs determine a threshold value to estimate the transcriptional similarity of iPSCs. The Distance index reflects the real distance of each cell type to the transcriptome distribution of ESCs in microarray space.
By applying multiple testing, we calculated the P-value and Benjamini-Hochberg FDR for the weight of each probe in vector . The significantly changed probes were isolated with a cut-off P-value of <0.001 and a FDR of <0.1. The probe sets were further converted to transcripts by Gene Name Bath Viewer (DAVID, http://david.abcc.ncifcrf.gov). We performed a functional analysis on the significantly changed genes on the DAVID bioinformatics resource .
Estimates of Human ES cell and neuron rosettes in the Human Differentiation Coordinate. The X-axis is the blast cell developing line; the Y-axis is the neuronal developing line. Ellipses were generated by the mean values and standard variances.
Maximizing the projection of each vector on the angle-bisector. Vector and existing in a 3-D space, represent a cell departed form state A, bypassing state B, finally reached to state C. First we transform location of to , then we get the angle , then generate one angle-bisector , and angle. On this angle-bisector, and are projections of Vector and . However, in this 3-D space, there exist a plane which is perpendicular to the plane ABC; each line passing point A are a angle-bisector of , all of them meeting our requirement. Obviously, when the included angle is minimized, the projection and are maximized, at this time, the maximized angel-bisector is uniquely determined by intersection of plane and plane ABC. When the dimensions of this space is over 3, the maximized angel-bisector is uniquely determined by intersection of all angle-bisector plane . So, when the angle-bisector exists in the subspace which is determined by the parent vector, the projection length of each vector is maximized. Proof: As we know, there exists a Let assume there is an satisfies thatThenThis is impossible. So there is no which can satisfy the condition of . Thus, is the longest bisector.
Noise Random permutation testing to developing line (GSE13149): The Projection location of Dataset GSE6998.
Distance-index of Human Embryonic Stem Cells.
Distance-index of Mouse Embryonic Stem Cells.
Distance-index of Human Induced Pluripotent Stem Cells.
Distance-index of Mouse Induced Pluripotent Stem Cells.
GO analysis of negative regulated genes in ES cell-derived Cardiac precursors cells Differentiation (GSE10970).
GO analysis of positive regulated genes in ES cell-derived Cardiac precursors cells Differentiation (GSE10970).
GO analysis of negative regulated genes in ES cell-derived Pancreatic islets cells Differentiation (GSE3653).
GO analysis of positive regulated genes in ES cell-derived Pancreatic islets cells Differentiation (GSE3653).
GO analysis of negative regulated genes in ES cell-derived blast cells Differentiation (GSE8884).
GO analysis of positive regulated genes in ES cell-derived blast cells Differentiation (GSE8884).
GO analysis of negative regulated genes in ES cell-derived neuron rosettes Differentiation (GSE9940).
GO analysis of positive regulated genes in ES cell-derived neuron rosettes Differentiation (GSE9940).
Positive regulated genes in ES cell-derived blast cell differentiation (GSE8884).
Negative regulated genes in ES cell-derived blast cell differentiation (GSE8884).
Positive regulated genes in ES cells-derived neuron rosette differentiation (GSE9940).
Positive regulated genes in ES cells-derived neuron rosette differentiation (GSE9940).
Negative regulated genes in ES cell-derived Cardiac precursors cells Differentiation (GSE10970).
Positive regulated genes in ES cell-derived Cardiac precursors cells Differentiation (GSE10970).
Negative regulated genes in ES cell-derived Pancreatic islets cells Differentiation (GSE3653).
Positive regulated genes in ES cell-derived Pancreatic islets cells Differentiation (GSE3653).
Significant Up-regulated Common Genes in GSE8884 and GSE9940.
Significant Down-regulated Common Genes in GSE8884 and GSE9940.
Significant Up-regulated Common Genes in GSE10970 and GSE3653.
Significant Down-regulated Common Genes in GSE10970 and GSE3653.
Noise Random permutation testing to developing line (GSE13149): The Projection location of Dataset GSE6998.
We are glad to thank Dr. Lei Xu and Mr. Shikui Tu for useful suggestion. We also thank Dr Geir Skogerbø for kindly discussions and suggestions.
Conceived and designed the experiments: BZ XZ TW. Analyzed the data: BZ BC. Contributed reagents/materials/analysis tools: YT SQ. Wrote the paper: BZ XZ ZX. Supervised the study: XZ RC.
- 1. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218–1221.
- 2. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277–280.
- 3. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, et al. (2009) Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6: 370–376.
- 4. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461: 402–406.
- 5. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964–977.
- 6. Urbach A, Bar-Nur O, Daley GQ, Benvenisty NDifferential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6: 407–411.
- 7. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111–123.
- 8. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5: e8975.
- 9. Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, et al. (2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461: 649–643.
- 10. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, et al. (2009) Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411–419.
- 11. Zhao XY, Li W, Lv Z, Liu L, Tong M, et al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461: 86–90.
- 12. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
- 13. Muzzafar T, Medeiros LJ, Wang SA, Brahmandam A, Thomas DA, et al. (2009) Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry. Am J Clin Pathol 132: 692–698.
- 14. Weng J, Krementsov DN, Khurana S, Roy NH, Thali M (2009) Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells. J Virol 83: 7467–7474.
- 15. Hatano H, Kudo Y, Ogawa I, Tsunematsu T, Kikuchi A, et al. (2008) IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 14: 6097–6105.
- 16. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315–322.
- 17. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41: 1350–1353.
- 18. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, et al. (2009) MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18: 749–758.
- 19. Pewsey E, Bruce C, Georgiou AS, Jones M, Baker D, et al. (2009) Proteomics analysis of epithelial cells reprogrammed in cell-free extract. Mol Cell Proteomics 8: 1401–1412.
- 20. Smith KP, Luong MX, Stein GS (2009) Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 220: 21–29.
- 21. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, et al. (2009) Adult mice generated from induced pluripotent stem cells. Nature 461: 91–94.
- 22. Ling Y, Sankpal UT, Robertson AK, McNally JG, Karpova T, et al. (2004) Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res 32: 598–610.
- 23. David G, Alland L, Hong SH, Wong CW, DePinho RA, et al. (1998) Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16: 2549–2556.
- 24. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375–386.
- 25. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463: 1035–1041.
- 26. Paulsson J (2005) Models of stochastic gene expression. Physics of Life Reviews 2: 157–175.
- 27. Bellomo N, Delitala M (2008) From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells. Physics of Life Reviews 5: 183–206.
- 28. LaVaute TM, Yoo YD, Pankratz MT, Weick JP, Gerstner JR, et al. (2009) Regulation of neural specification from human embryonic stem cells by BMP and FGF. Stem Cells 27: 1741–1749.
- 29. Lu SJ, Hipp JA, Feng Q, Hipp JD, Lanza R, et al. (2007) GeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes. Genome Biol 8: R240.
- 30. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, et al. (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340–345.
- 31. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276–1284.
- 32. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797–801.
- 33. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472–476.
- 34. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141–146.
- 35. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105: 2883–2888.
- 36. Miller RA, Christoforou N, Pevsner J, McCallion AS, Gearhart JD (2008) Efficient array-based identification of novel cardiac genes through differentiation of mouse ESCs. PLoS One 3: e2176.
- 37. Treff NR, Vincent RK, Budde ML, Browning VL, Magliocca JF, et al. (2006) Differentiation of embryonic stem cells conditionally expressing neurogenin 3. Stem Cells 24: 2529–2537.
- 38. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, et al. (2008) Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646–650.
- 39. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, et al. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49–55.
- 40. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, et al. (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136: 364–377.
- 41. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553–560.
- 42. Nord AS, Vranizan K, Tingley W, Zambon AC, Hanspers K, et al. (2007) Modeling insertional mutagenesis using gene length and expression in murine embryonic stem cells. PLoS One 2: e617.